Revenue: As of FY2025 Q1, the actual value is USD 2.878 B.

EPS: As of FY2025 Q1, the actual value is USD 0.14.

EBIT: As of FY2025 Q1, the actual value is USD 91.57 M.

Segment Revenue

• Pharmacy Solutions Revenue: $2,532 million, up 28% from $1,977 million in the first quarter of 2024.
• Provider Services Revenue: $346 million, up 12% from $309 million in the first quarter of 2024.

Operational Metrics

• Net Income from Continuing Operations: $9.2 million, compared to a Net Loss of $56.0 million in the first quarter of 2024.
• Gross Profit: $338 million, up 15.7% from $292 million in the first quarter of 2024.
• Operating Income: $50.7 million, compared to an Operating Loss of - $15.3 million in the first quarter of 2024.

Cash Flow

• Net Cash Provided by Operating Activities: $101.6 million, compared to - $78.9 million in the first quarter of 2024.

Unique Metrics

• Adjusted EBITDA: $131 million, up 28.2% from $102 million in the first quarter of 2024.

Outlook / Guidance

BrightSpring Health Services has increased its full-year 2025 guidance, projecting net revenue between $12,000 million and $12,500 million, and Adjusted EBITDA between $570 million and $585 million. The Pharmacy Segment Revenue is expected to grow between 20.5% and 25.7%, while the Provider Segment Revenue is anticipated to increase between 10.0% and 13.8%.